PP-161 Cryptococcus meningitis in an AIDS patient exacerbated by corticosteroids: a case report  by Hu, Z.L. et al.
S90 Abstracts, 5th DICID
and re-analyzing individual patient data across clinical
trials in recent years, but got opposite conclusions. In
this review, we summarize the controversial data in the
past decades and analysis the potential reasons for the
different therapeutic effects of corticosteroids in AH.
Steroid resistance, widely prevailed in AH patients, is the
paramount reason for the poor prognosis of AH patients
during steroids therapy. Early response to glucocorticoids,
determined by calculating the Lille score after 7 days
of treatment, has been shown to be a clinically useful
indicator. Moreover, the development/worsening of severe
infections, the most worrisome of complications during
corticosteroids treatment AH, has also been demonstrated
to be mainly associated with non-responsiveness rather than
corticosteroids treatment itself. Improving the impaired
steroids sensitivity, reducing the infection risk and
rationalizing the therapeutic strategy of corticosteroids in
AH patients are crucial for therapeutic effect. We need to
look beyond the traditional debate and view the use of
corticosteroids in AH from a fresh perspective.
PP-159 Application and predictive value of indocyanine
green (ICG) clearance test by pulse dye
densitometry (PDD) in patients with liver
failure
A.-R. Hu1 *, S.-W. Jiang1, J.-M. Ye1. 1Ningbo No.2 Hospital,
Ningbo Infectious Diseases Hospital, China
Objective: The aim of this study was to investigate the
efﬁcacy and the value of indocyanine green retention at
ﬁfteen minutes (ICGR15) for hepatic reserve function in
patients with liver failure by pulse dye densitometry (PDD).
Methods: Among 127 cases with liver failure, there were
3 cases with ALF, 26 cases with SALF, 58 cases with ACLF
and 40 cases with CLF. According to clinical outcome at
discharge, all patients were divided into cured restorative
group (80 cases) and untreated group (47 cases). 23 patients
with tendency to liver failure were served as control group.
The ICGR15 (the unit was %) of all 150 patients were
measured by PDD.
Results: The basic ICGR15 values were 53.31±11.22 in
patients with liver failure and 48.33±10.28 in patients with
tendency to liver failure, 48.83±10.43 in cured restorative
group and 60.95±7.95 in untreated group. The differences
were statistically signiﬁcant (t = 1.983, P = 0.049; t = 6.874,
P < 0.001). Compared to gender distribution, there was no
signiﬁcant difference with ICGR15 in patients with liver
failure, but was statistically signiﬁcant compared to age
distribution (50 years as the limit) (t = 4.254, P < 0.001). The
basic ICGR15 values were statistically signiﬁcant among the
patients with CLF, SALF and ACLF (F = 7.222, 5.394, 9.088;
P = 0.009, 0.017, 0.002), and were statistically signiﬁcant
among early stage, medium stage and end stage of liver
failure. The dynamic ICGR15 values were no signiﬁcant
difference with the basic values in cured restorative
group (t = 0.956, P = 0.341), but in untreated group were
signiﬁcantly higher than the basic values (66.97±7.01 VS
60.95±7.95; t = 3.891, P < 0.001). The changes of dynamic
ICGR15 values were mainly rising in untreated group (86.42%)
(c2 = 59.349, P < 0.001). The areas under the ROC curve
(AUC) of PT, CTP, MELD, basic ICGR15 values and dynamic
ICGR15 values to predict the prognosis of liver failure were
0.823, 0.711, 0.862, 0.824 and 0.960.
Conclusion: If the indocyanine green clearance test is used
in patients with liver failure, the values of ICGR15 will be
a good indicator to evaluate the patients’ liver function,
disease severity and prognosis.
PP-160 Lamivudine treatment is associated with
improved survival in fulminant hepatitis B
J.-W. Yu1 *, L.-J. Sun1. 1Department of Infectious Diseases,
Second Afﬁliated Hospital, Harbin Medical University,
China
To evaluate the efﬁcacy of lamivudine in patients with
fulminant hepatitis B and study the prognostic factors.
Methods: A matched retrospective cohort study using
data on fulminant hepatitis B patients derived from our
hospital database was conducted. Forty patients receiving
lamivudine treatment were selected into the lamivudine
treatment group with another 40 without lamivudine
treatment studied as control. The mortality of patients
in two groups was compared. The inﬂuential factors on the
mortality were studied by Cox proportional hazards model.
Results: The mortality of patients in the lamivudine group
(n = 38) was signiﬁcantly lower than that of control group
(n = 39) (63.2% vs. 84.6%; X2 = 4.609, P = 0.032). For patients
without SIRS, the mortality of patients in the lamivudine
group (n = 25) was signiﬁcantly lower than that of control
group (n = 26) (52.0% vs. 80.8%; X2 = 4.747, P = 0.029). In
multivariate Cox proportional hazards analyses, for patients
without SIRS, age (P = 0.037), ratio of total to direct bilirubin
(P = 0.008), treatment method (P = 0.005) and the decline of
HBV DNA load during therapy (P = 0.019) were independent
predictors of prognosis.
Conclusions: Treatment with lamivudine signiﬁcantly
decreases the mortality of fulminant hepatitis B patients
without SIRS, and a rapid decline of HBV DNA load is one of
good predictors for the treatment outcome.
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Introduction: Cryptococcus meningitis (CM) is a common
cause of mortality in advanced HIV infected patients. Use
of corticosteroid and immunosuppressive drugs can also
make a person more susceptible to CM.
Case Description: We report the case of a 35-year-old
male with CM that was exacerbated by corticosteroids.
The patient complained fever and headache 1 week
after commencing HAART. He was misdiagnosis with
viral meningitis which was coincidently relieved by
ﬂuconazole therapy for oral candidiasis. His headache
reoccurred after 38 days during which we produced
ﬁve lumbar punctures that showed relatively normal CSF
biochemistry and pressure ﬁnding. India ink preparation,
alcian blue stain and CSF/blood culture couldn’t conﬁrm a
CM. Diagnostic anti-tuberculosis treatment was initiated
in combination with 10mg/day dexamethasone. Fever
reappearanced 3 days later. Immune reconstitution
inﬂammatory syndrome was suspected and the patient was
received 160mg/per meprednisone for two days. Fever
and headache exacerbated and seizure occurred. Lumbar
punture showed elevated CSF open pressure (620mmH2O),
worsed routine biochemical test and positive culture and
stain for Cryptococcus neoformans. His disease quickly
progressed with serious hearing/vision impairment and
frequent onset of seizure and coma although steroids were
withdrawn and antifungal therapy initiated.
Corticosteroids should be used cautiously when CM couldn’t
be excluded.
